The phase II study of efficacy and safety of oxaliplatin with doxorubicin in recurrent ovarian cancer (OC).
I. Pokataev
No relevant relationships to disclose
G. M. Manikhas
No relevant relationships to disclose
V. Borisov
No relevant relationships to disclose
M. Stenina
No relevant relationships to disclose
A. Tjulandina
No relevant relationships to disclose
S. Tjulandin
No relevant relationships to disclose